Nina S Kjellson - Net Worth and Insider Trading

Nina S Kjellson Net Worth

The estimated net worth of Nina S Kjellson is at least $948,133 dollars as of 2024-05-13. Nina S Kjellson is the Director of Cidara Therapeutics Inc and owns about 67,841 shares of Cidara Therapeutics Inc (CDTX) stock worth over $824,947. Nina S Kjellson is also the Director of Ocera Therapeutics Inc and owns about 68,819 shares of Ocera Therapeutics Inc (OCRX) stock worth over $123,186. Details can be seen in Nina S Kjellson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nina S Kjellson has not made any transactions after 2015-04-20 and currently still holds the listed stock(s).

Transaction Summary of Nina S Kjellson

Nina S Kjellson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nina S Kjellson owns 12 companies in total, including Ocera Therapeutics Inc (OCRX) , Eiger BioPharmaceuticals Inc (EIGRQ) , and Glaukos Corp (GKOS) among others .

Click here to see the complete history of Nina S Kjellson’s form 4 insider trades.

Insider Ownership Summary of Nina S Kjellson

Ticker	Comapny	Transaction Date	Type of Owner
OCRX	Ocera Therapeutics Inc	2017-12-11	director
EIGRQ	Eiger BioPharmaceuticals Inc	2016-03-22	director & 10 percent owner
GKOS	Glaukos Corp	2015-06-24	10 percent owner
		2015-06-18	10 percent owner
		2015-04-20	director
		2015-04-08	10 percent owner
		2014-05-29	10 percent owner
		2013-08-05	other: Former 10% Owner
		2011-09-20	10 percent owner
		2007-11-20	10 percent owner
		2021-04-06	director
		2021-09-14	director

Nina S Kjellson Latest Holdings Summary

Nina S Kjellson currently owns a total of 2 stocks. Among these stocks, Nina S Kjellson owns 67,841 shares of Cidara Therapeutics Inc (CDTX) as of April 20, 2015, with a value of $824,947 and a weighting of 87.01%. Nina S Kjellson also owns 68,819 shares of Ocera Therapeutics Inc (OCRX) as of July 15, 2013, with a value of $123,186 and a weighting of 12.99%.

Latest Holdings of Nina S Kjellson

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CDTX	Cidara Therapeutics Inc	2015-04-20	67,841	12.16	824,947
OCRX	Ocera Therapeutics Inc	2013-07-15	68,819	1.79	123,186

Holding Weightings of Nina S Kjellson

Nina S Kjellson Form 4 Trading Tracker

According to the SEC Form 4 filings, Nina S Kjellson has made a total of 0 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years. The most-recent trade in Cidara Therapeutics Inc is the acquisition of 10,000 shares on April 20, 2015, which cost Nina S Kjellson around $3 Million.

According to the SEC Form 4 filings, Nina S Kjellson has made a total of 0 transactions in Ocera Therapeutics Inc (OCRX) over the past 5 years. The most-recent trade in Ocera Therapeutics Inc is the acquisition of 35,953 shares on July 15, 2013, which cost Nina S Kjellson around $3 Million.

Insider Trading History of Nina S Kjellson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nina S Kjellson Trading Performance

GuruFocus tracks the stock performance after each of Nina S Kjellson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nina S Kjellson is 21.49%. GuruFocus also compares Nina S Kjellson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nina S Kjellson within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nina S Kjellson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nina S Kjellson

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	13.56
Relative Return to S&P 500(%)	13.58

Nina S Kjellson Ownership Network

Ownership Network List of Nina S Kjellson

No Data

Ownership Network Relation of Nina S Kjellson

Nina S Kjellson Owned Company Details

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Nina S Kjellson is the director of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does Eiger BioPharmaceuticals Inc do?

Who are the key executives at Eiger BioPharmaceuticals Inc?

Nina S Kjellson is the director & 10 percent owner of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .

Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary

Over the past 18 months, Nina S Kjellson made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 27,500 shares made by Thomas John Dietz , a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 100,000 shares made by Jeffrey S Glenn .

In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 896 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 15,086 shares were bought by its insiders, resulting in a net purchase of 14,189 shares.

Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eiger BioPharmaceuticals Inc Insider Transactions

No Available Data

What does Glaukos Corp do?

Who are the key executives at Glaukos Corp?

Nina S Kjellson is the 10 percent owner of Glaukos Corp. Other key executives at Glaukos Corp include SVP & Chief Financial Officer Alex R. Thurman , CFO & SVP Corporate Development Joseph E Gilliam , and director & 10 percent owner & Chief Executive Officer Thomas William Burns .

Glaukos Corp (GKOS) Insider Trades Summary

Over the past 18 months, Nina S Kjellson made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 520,000 shares made by Thomas William Burns , a net sale of 297,009 shares made by Joseph E Gilliam , and a net sale of 6,409 shares made by Alex R. Thurman .

In summary, during the past 3 months, insiders sold 240,614 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 240,614 shares. During the past 18 months, 881,825 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 881,825 shares.

Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glaukos Corp Insider Transactions

No Available Data

What does Invuity Inc do?

Who are the key executives at Invuity Inc?

Nina S Kjellson is the 10 percent owner of Invuity Inc. Other key executives at Invuity Inc include Chief Financial Officer James H Mackaness , 10 percent owner & other: Possible Member of 10% Group James E Flynn , and 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) .

Invuity Inc (IVTY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Invuity Inc Insider Transactions

No Available Data

What does Cidara Therapeutics Inc do?

Who are the key executives at Cidara Therapeutics Inc?

Nina S Kjellson is the director of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and CFO & CBO Preetam Shah .

Cidara Therapeutics Inc (CDTX) Insider Trades Summary

Over the past 18 months, Nina S Kjellson made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 48,874 shares made by Leslie Tari , a net sale of 46,658 shares made by Taylor Sandison , and a net purchase of 100,000 shares made by Jeffrey Stein .

In summary, during the past 3 months, insiders sold 4,055 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 4,055 shares. During the past 18 months, 7,796 shares of Cidara Therapeutics Inc (CDTX) were sold and 5,500 shares were bought by its insiders, resulting in a net sale of 2,296 shares.

Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cidara Therapeutics Inc Insider Transactions

No Available Data

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

Nina S Kjellson is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include director & President and CEO Thomas Andrew Crockett , Chief Medical Officer Paul K. Audhya , and CFO and Secretary Benjamin L Palleiko .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, Nina S Kjellson made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 167,039 shares made by Thomas Andrew Crockett , and a net sale of 110,937 shares made by Edward P. Feener .

In summary, during the past 3 months, insiders sold 269,594 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 269,594 shares. During the past 18 months, 505,299 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 745,718 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

What does Marketo Inc do?

Who are the key executives at Marketo Inc?

Nina S Kjellson is the 10 percent owner of Marketo Inc. Other key executives at Marketo Inc include SVP & Chief Financial Officer Brian K Kinion , EVP Worldwide Field Operations Steven M Winter , and SVP & GC & Secretary Margo Smith .

Marketo Inc (MKTO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marketo Inc (MKTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marketo Inc (MKTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marketo Inc (MKTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marketo Inc Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Nina S Kjellson is the other: Former 10% Owner of Tesaro Inc. Other key executives at Tesaro Inc include SVP & Chief Medical Officer Huber Martin H. Jr. , 10 percent owner New Enterprise Associates 13 Lp , and 10 percent owner Nea 13 Gp, Ltd .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Nina S Kjellson is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Nina S Kjellson made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 172,206 shares made by Evan Loh , a net sale of 98,375 shares made by Michael Bigham , and a net sale of 79,527 shares made by William M. Haskel .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 442,355 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 346,145 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Nina S Kjellson is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

What does Panacea Acquisition Corp II do?

Who are the key executives at Panacea Acquisition Corp II?

Nina S Kjellson is the director of Panacea Acquisition Corp II. Other key executives at Panacea Acquisition Corp II include director & 10 percent owner Ecor1 Capital Fund Qualified, L.p. , director & 10 percent owner Ecor1 Capital, Llc , and director & 10 percent owner Oleg Nodelman .

Panacea Acquisition Corp II (PANA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Panacea Acquisition Corp II (PANA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Panacea Acquisition Corp II (PANA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Panacea Acquisition Corp II (PANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Panacea Acquisition Corp II Insider Transactions

No Available Data

What does Tyra Biosciences Inc do?

Who are the key executives at Tyra Biosciences Inc?

Nina S Kjellson is the director of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include Chief Operating Officer Daniel Bensen , director & Chief Executive Officer Todd Harris , and 10 percent owner Mva Investors, Llc .

Tyra Biosciences Inc (TYRA) Insider Trades Summary

Over the past 18 months, Nina S Kjellson made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 276,298 shares made by Daniel Bensen , a net sale of 252,175 shares made by Todd Harris , and a net sale of 265,568 shares made by Mva Investors, Llc .

In summary, during the past 3 months, insiders sold 19,797 shares of Tyra Biosciences Inc (TYRA) in total and bought 0 shares, with a net sale of 19,797 shares. During the past 18 months, 794,041 shares of Tyra Biosciences Inc (TYRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 794,041 shares.

Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tyra Biosciences Inc Insider Transactions

No Available Data

Nina S Kjellson Mailing Address

Above is the net worth, insider trading, and ownership report for Nina S Kjellson. You might contact Nina S Kjellson via mailing address: C/o Interwest Partners, 2710 Sand Hill Road, Suite 200, Menlo Park Ca 94025.

Discussions on Nina S Kjellson

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.